Published in Am J Obstet Gynecol on May 14, 2012
Maternal immunization. Clinical experiences, challenges, and opportunities in vaccine acceptance. Hum Vaccin Immunother (2014) 2.11
Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ (2014) 1.58
Pertussis re-emergence in the post-vaccination era. BMC Infect Dis (2013) 1.44
Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin Microbiol Rev (2016) 1.07
Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes. J Pediatr (2013) 0.93
Pertussis. Hum Vaccin Immunother (2014) 0.88
Revised adult immunization guideline recommended by the korean society of infectious diseases, 2014. Infect Chemother (2015) 0.84
The Centers for Disease Control and Prevention's public health response to monitoring Tdap safety in pregnant women in the United States. Hum Vaccin Immunother (2015) 0.84
Dismantling the Taboo against Vaccines in Pregnancy. Int J Mol Sci (2016) 0.80
The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014. Public Health Rep (2015) 0.79
Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine (2016) 0.78
Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study. BMJ Open (2016) 0.77
Safety of Tdap vaccine in pregnant women: an observational study. BMJ Open (2016) 0.76
Antenatal immunization. Hum Vaccin Immunother (2014) 0.76
A systematic review of ethical issues in vaccine studies involving pregnant women. Hum Vaccin Immunother (2016) 0.76
Pertussis in young infants: a severe vaccine-preventable disease. Autops Case Rep (2015) 0.76
Randomized clinical trial of the safety and immunogenicity of the Tdap vaccine in pregnant Mexican women. Hum Vaccin Immunother (2016) 0.75
Issues in pediatric vaccine-preventable diseases in low- to middle-income countries. Hum Vaccin Immunother (2016) 0.75
Maternal and infant outcomes among women vaccinated against pertussis during pregnancy. Hum Vaccin Immunother (2016) 0.75
Reporting vaccine complications: what do obstetricians and gynecologists know about the Vaccine Adverse Event Reporting System? Infect Dis Obstet Gynecol (2013) 0.75
Statistical and Ontological Analysis of Adverse Events Associated with Monovalent and Combination Vaccines against Hepatitis A and B Diseases. Sci Rep (2016) 0.75
Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine (2016) 0.75
Combined reduced-antigen content tetanus, diphtheria, and acellular pertussis (tdap) vaccine-related erythema nodosum: case report and review of vaccine-associated erythema nodosum. Dermatol Ther (Heidelb) (2013) 0.75
Maternal death: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine (2016) 0.75
The safety of maternal immunization. Hum Vaccin Immunother (2016) 0.75
Forecasting Epidemiological Consequences of Maternal Immunization. Clin Infect Dis (2016) 0.75
Assessing the Evidence for Maternal Pertussis Immunization: A Report From the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income Countries. Clin Infect Dis (2016) 0.75
Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine (2016) 0.75
H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet (2009) 12.32
Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med (2005) 6.83
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA (2010) 5.94
Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA (2009) 5.58
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep (2007) 5.32
Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics (2005) 4.91
Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol (2011) 4.14
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet (2009) 4.07
Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med (2007) 3.79
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet (2002) 3.35
Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg Infect Dis (2005) 3.09
The contribution of preterm birth to infant mortality rates in the United States. Pediatrics (2006) 3.01
A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics (2003) 2.88
A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol (2011) 2.75
Emerging infections and pregnancy. Emerg Infect Dis (2006) 2.75
Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics (2006) 2.53
Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med (2007) 2.43
A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001. Pharmacoepidemiol Drug Saf (2004) 2.37
Maternal obesity and risk for birth defects. Pediatrics (2003) 2.33
Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA (2005) 2.21
Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. J Infect Dis (2008) 2.14
What obstetrician-gynecologists should know about Ebola: a perspective from the Centers for Disease Control and Prevention. Obstet Gynecol (2014) 2.04
Safety of influenza A (H1N1) 2009 live attenuated monovalent vaccine in pregnant women. Obstet Gynecol (2013) 2.04
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep (2014) 1.97
A multicenter intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol (2006) 1.93
Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B. Clin Gastroenterol Hepatol (2012) 1.84
Adverse events reported following live, cold-adapted, intranasal influenza vaccine. JAMA (2005) 1.84
Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet (2013) 1.82
National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial (2005) 1.75
NLP-based identification of pneumonia cases from free-text radiological reports. AMIA Annu Symp Proc (2008) 1.74
Maternal nutrient intakes and risk of orofacial clefts. Epidemiology (2006) 1.70
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001. MMWR Surveill Summ (2003) 1.70
2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol (2011) 1.69
Association between pregnancy intention and reproductive-health related behaviors before and after pregnancy recognition, National Birth Defects Prevention Study, 1997-2002. Matern Child Health J (2009) 1.68
Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology (2007) 1.67
Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol (2011) 1.66
Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2008) 1.65
Prescription medication borrowing and sharing among women of reproductive age. J Womens Health (Larchmt) (2008) 1.64
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season. MMWR Morb Mortal Wkly Rep (2015) 1.64
A population-based study of craniosynostosis in metropolitan Atlanta, 1989-2003. Am J Med Genet A (2008) 1.63
Are children born after assisted reproductive technology at increased risk for adverse health outcomes? Obstet Gynecol (2004) 1.61
Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med (2014) 1.59
Lack of association of Guillain-Barré syndrome with vaccinations. Clin Infect Dis (2013) 1.58
Identification of reptilian and amphibian blood meals from mosquitoes in an eastern equine encephalomyelitis virus focus in central Alabama. Am J Trop Med Hyg (2004) 1.57
Enhanced identification of postoperative infections among inpatients. Emerg Infect Dis (2004) 1.56
Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.56
Orofacial clefts in the National Birth Defects Prevention Study, 1997-2004. Am J Med Genet A (2009) 1.55
Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study. Pediatrics (2008) 1.54
Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep (2004) 1.52
Health concerns of women and infants in times of natural disasters: lessons learned from Hurricane Katrina. Matern Child Health J (2007) 1.48
Contraceptive Use Among Women With Medical Conditions in a Nationwide Privately Insured Population. Obstet Gynecol (2015) 1.48
Computer algorithms to detect bloodstream infections. Emerg Infect Dis (2004) 1.48
Vaccination and risk of type 1 diabetes mellitus in active component U.S. Military, 2002-2008. Vaccine (2011) 1.47
Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine (2009) 1.40
Ethanol Extract from Ampelopsis sinica Root Exerts Anti-Hepatitis B Virus Activity via Inhibition of p53 Pathway In Vitro. Evid Based Complement Alternat Med (2011) 1.39
Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol (2009) 1.38
Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol (2007) 1.34
Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Am J Infect Control (2005) 1.33
Prevention and Control of Seasonal Influenza with Vaccines. MMWR Recomm Rep (2016) 1.32
Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.29
Patterns of antidepressant medication use among pregnant women in a United States population. J Clin Pharmacol (2010) 1.28
Nrf2 Possesses a redox-insensitive nuclear export signal overlapping with the leucine zipper motif. J Biol Chem (2005) 1.27
Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Am J Epidemiol (2012) 1.27
Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol (2005) 1.27
Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol (2010) 1.25
Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol (2011) 1.25
The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol (2011) 1.24
Trends and correlates of good perinatal outcomes in assisted reproductive technology. Obstet Gynecol (2012) 1.23
Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US. Antivir Ther (2012) 1.22
Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). Sex Transm Dis (2011) 1.21
Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine (2010) 1.21
Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.21
Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010. Am J Epidemiol (2012) 1.20
Zoonotic helminth infections of humans: echinococcosis, cysticercosis and fascioliasis. Curr Opin Infect Dis (2007) 1.20
Maternal attitudes toward DNA collection for gene-environment studies: a qualitative research study. Am J Med Genet A (2009) 1.18
Priorities for future public health research in orofacial clefts. Cleft Palate Craniofac J (2007) 1.18
Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J Infect Dis (2008) 1.18
Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature. Am J Med Genet A (2009) 1.17
U.S. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR Recomm Rep (2016) 1.16
Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn. N Engl J Med (2006) 1.16
Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR Recomm Rep (2006) 1.14
Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2010) 1.14
Maternal periconceptional alcohol consumption and risk of orofacial clefts. Am J Epidemiol (2007) 1.13
Correlates of seasonal influenza vaccine coverage among pregnant women in Georgia and Rhode Island. Obstet Gynecol (2010) 1.13
H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. Am J Prev Med (2011) 1.12
Lymphocytic choriomeningitis virus: an emerging obstetric pathogen? Am J Obstet Gynecol (2006) 1.11
Prophylaxis and treatment of pregnant women for emerging infections and bioterrorism emergencies. Emerg Infect Dis (2006) 1.11
Medication use during pregnancy and lactation: an urgent call for public health action. J Womens Health (Larchmt) (2005) 1.10
Elective single embryo transfer trends and predictors of a good perinatal outcome--United States, 1999 to 2010. Fertil Steril (2013) 1.08
Zika Virus Infection Among U.S. Pregnant Travelers - August 2015-February 2016. MMWR Morb Mortal Wkly Rep (2016) 1.08
Accuracy of assisted reproductive technology information on birth certificates: Florida and Massachusetts, 2004-06. Paediatr Perinat Epidemiol (2014) 1.07
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep (2016) 1.07